UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000035753
Receipt No. R000040728
Scientific Title The Evaluation of Efficacy and Safety of Rituximab (Genetical Recombination) in Refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients with Immunoglobulin G4 (IgG4) Autoantibodies in the Exploratory Clinical Trial
Date of disclosure of the study information 2019/02/02
Last modified on 2019/03/28 16:51:19

No. Disposal Last modified on Item of update
1 Insert 2019/02/02 16:01:11
2 Update 2019/03/28 16:48:34 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Study ID_2
Org. issuing International ID_2
Org. issuing International ID_2
3 Update 2019/03/28 16:51:19 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date


Contact us.